Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₩1,067, the stock trades at a trailing P/E ratio of 16.7x. Average trailing P/E is 14x in the Medical Equipment industry in South Korea. Total returns to shareholders of 4.3% over the past year. Valuation Update With 7 Day Price Move • Jun 19
Investor sentiment improves as stock rises 31% After last week's 31% share price gain to ₩1,618, the stock trades at a trailing P/E ratio of 25.3x. Average trailing P/E is 15x in the Medical Equipment industry in South Korea. Total returns to shareholders of 75% over the past year. New Risk • Jun 01
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩145.6b (US$96.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (27% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩145.6b market cap, or US$96.5m). Valuation Update With 7 Day Price Move • Jun 01
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₩1,410, the stock trades at a trailing P/E ratio of 22x. Average trailing P/E is 15x in the Medical Equipment industry in South Korea. Total returns to shareholders of 53% over the past year. Valuation Update With 7 Day Price Move • Mar 31
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩2,185, the stock trades at a trailing P/E ratio of 34.7x. Average trailing P/E is 18x in the Medical Equipment industry in South Korea. Total returns to shareholders of 133% over the past year. 공고 • Mar 17
CG MedTech Co.,Ltd., Annual General Meeting, Mar 27, 2026 CG MedTech Co.,Ltd., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 20, sandan-ro 76beon-gil, gyeonggi-do, uijeongbu South Korea Valuation Update With 7 Day Price Move • Mar 16
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩2,835, the stock trades at a trailing P/E ratio of 76.1x. Average trailing P/E is 17x in the Medical Equipment industry in South Korea. Total returns to shareholders of 221% over the past year. Valuation Update With 7 Day Price Move • Feb 20
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₩2,305, the stock trades at a trailing P/E ratio of 61.8x. Average trailing P/E is 21x in the Medical Equipment industry in South Korea. Total returns to shareholders of 134% over the past year. New Risk • Feb 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Feb 04
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to ₩1,875, the stock trades at a trailing P/E ratio of 50.3x. Average trailing P/E is 20x in the Medical Equipment industry in South Korea. Total returns to shareholders of 78% over the past year. Valuation Update With 7 Day Price Move • Jan 05
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₩1,436, the stock trades at a trailing P/E ratio of 38.5x. Average trailing P/E is 20x in the Medical Equipment industry in South Korea. Total returns to shareholders of 22% over the past three years. Valuation Update With 7 Day Price Move • Dec 10
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to ₩1,325, the stock trades at a trailing P/E ratio of 35.5x. Average trailing P/E is 19x in the Medical Equipment industry in South Korea. Total returns to shareholders of 12% over the past three years. 공고 • Mar 13
CG MedTech Co.,Ltd., Annual General Meeting, Mar 28, 2025 CG MedTech Co.,Ltd., Annual General Meeting, Mar 28, 2025, at 09:01 Tokyo Standard Time. Location: conference room, 20, sandan-ro 76beon-gil, gyeonggi-do, uijeongbu South Korea New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 31% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩111.8b market cap, or US$76.7m). 공고 • Aug 07
Innosys Co., Ltd. (KOSDAQ:A056090) agreed to acquire GDS Co., Ltd. for KRW 4 billion. Innosys Co., Ltd. (KOSDAQ:A056090) agreed to acquire GDS Co., Ltd. for KRW 4 billion on August 5, 2024. A cash consideration of KRW 4 billion will be paid by Innosys Co., Ltd. As part of consideration, KRW 4 billion is paid towards common equity of GDS Co., Ltd.
The expected completion of the transaction is August 13, 2024. 공고 • Feb 13
Innosys Co., Ltd. announced that it has received KRW 10.00000001 billion in funding from CG Bio Co., Ltd. On February 13, 2024, Innosys Co., Ltd. closed the transaction. 공고 • Jul 20
Edisoninno Co., Ltd. announced that it has received KRW 9.999995684 billion in funding from J-Space Holdings Co., Ltd. On July 19, 2022, Edisoninno Co., Ltd. closed the transaction. 공고 • Jul 19
Edisoninno Co., Ltd. announced that it has received KRW 20 billion in funding On July 18, 2022, Edisoninno Co., Ltd. closed the transaction. Is New 90 Day High Low • Mar 11
New 90-day low: ₩4,400 The company is down 13% from its price of ₩5,030 on 11 December 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 6.0% over the same period. Is New 90 Day High Low • Nov 24
New 90-day high: ₩5,350 The company is up 43% from its price of ₩3,740 on 26 August 2020. The South Korean market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Medical Equipment industry, which is up 2.0% over the same period. 
